Ahmad Shabsigh MD , MBA (He/Him)

Minimally Invasive Surgery, Surgical Oncology

Medical Director of Enhanced Surgical Recovery Associate medical director of perioperative quality and safety. OSU Comprehensive Cancer Center Vice chair for quality. Department of Urology, Ohio State University College of Medicine

Join to view full profile

300 W 10th AveColumbus, OH 43210
Phone+1 614-685-4263
Fax+1 614-685-4768

Dr. Shabsigh is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shabsigh's full profile Already have an account?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2001 - 2008
New York Presbyterian HospitalInternship, Transitional Year, 2000 - 2001
University of Aleppo Faculty of MedicineClass of 1995

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OH State Medical License 2008 - 2028
NY State Medical License 2005 - 2012
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Biomarker Identification for Bladder Cancer Patients Start of enrollment: 2014 Jan 21
TERMINATED
Blue Light Cystoscopy With Cysview® Registry
RECRUITING
Postoperative Delirium in Patients Undergoing Radical Cystectomy Start of enrollment: 2018 Jan 10
COMPLETED
NA

Publications & Presentations

PubMed

Adenoid Cystic Carcinoma of the Perineum Presenting as a Decade of Chronic Pelvic Pain.
Claire Haas, Debra Zynger, Ahmad Shabsigh
Urology. 2026-08-06
NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026.
Daniel E Spratt, Sandy Srinivas, Nabil Adra, Bilawal Ahmed, Yi An
Journal of the National Comprehensive Cancer Network. 2026-05-01
Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS-CoV-2 (COVID-19).
Alexander Yaney, Jonathan E Schoenhals, Yevgeniya Gokun, Andrew Stevens, Jack Wang
Prostate Cancer. 2026-01-01

Journal Articles

Multi-Institutional Experience with Robotic Nephrectomy with Inferior Vena Cava Tumor Thrombectomy
Mani Menon, Ahmad Shabsigh, Daniel Eun, Craig Rogers, Monish Aron, Erik Castle, Mohamad Allaf, Chandru P Sundaram, Ronney Abaza, Jim C Hu, The Journal of Urology

Press Mentions

Study Shows Favorable Outcomes with Guideline-Based Treatment for Localized Prostate CancerJuly 14th, 2025
Prostate Cancer Is Unlikely to Kill Men if It's Low Risk and Treated According to Best Practices, Study FindsJuly 10th, 2025
New Research Offers Reassurance About Localized Prostate Cancer PrognosisJuly 10th, 2025